Audit 309851

FY End
2023-09-30
Total Expended
$933.79M
Findings
0
Programs
579
Organization: Research Triangle Institute (NC)
Year: 2023 Accepted: 2024-06-25

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.RD 2023 Nsduh $30.52M - 0
93.RD Dc Kcc $24.12M - 0
93.RD Pcf By/oy5 $20.31M - 0
12.560 Dod, Ndep, Dotc-Stem Education Outreach Implementation $19.88M - 0
93.RD 19 Ot 3.1 Redesign Ft $18.51M - 0
93.RD Bp T M Aco Paos 2 $12.61M - 0
93.RD Coding $12.48M - 0
98.U56 Pep Clin 1 $12.09M - 0
98.U58 Jifunze Uelewe $11.51M - 0
84.RD Bp Core Tasks Clin1 Nonit $10.55M - 0
98.U38 Power Africa Off-Grid Pro $9.19M Yes 0
93.310 Trans-Nih Research Support $8.48M - 0
98.U38 East Africa To2 $8.16M Yes 0
98.U54 Sarep $7.76M - 0
84.RD 2 Icils Travel $7.64M - 0
93.RD Nscaw - Clin 1 $7.63M - 0
17.207 Employment Service/wagner-Peyser Funded Activities $7.16M - 0
98.U76 Fast Implementation $6.91M Yes 0
93.RD Clin 3 Comm. with Nchs $6.79M - 0
98.U54 Energy Secure Philippines $6.67M - 0
98.U71 Project Implementation $6.46M Yes 0
98.U55 Ipea Accurals $6.37M - 0
98.U57 Technical Assistance $6.17M - 0
98.U54 C4g Base Period $5.83M - 0
84.RD N24 Task 3 $5.61M - 0
16.RD Nflis Comm and Outreach $5.57M - 0
98.U24 Tusome—early Grade Reading Program in Kenya $5.26M Yes 0
98.001 Covid-19 - Usaid Foreign Assistance for Programs Overseas $5.05M Yes 0
16.739 National Prison Rape Statistics Program $4.94M - 0
16.RD Namus Clin 0003 $4.84M - 0
98.U69 Grants Under Contract $4.64M Yes 0
98.U50 Kyrgyz Assess and Evals $4.64M - 0
93.RD Cc4carb by Lab $4.63M - 0
98.U70 Test Inclusive Ed Rollup $4.57M - 0
93.RD Demme Stage Two $4.44M - 0
93.RD Ntp Option Period 8 $4.27M - 0
84.RD Bps 20 22 Opt Task 5 $4.20M - 0
93.RD Covid-19 - 2023 Nsduh Fy23 $4.00M - 0
66.RD Tech Supp Ghgrp Bp $3.61M - 0
93.RD Nhanes Bp Mec Build $3.39M - 0
93.318 Covid-19 - Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security $3.32M - 0
84.RD Ipeds 22 23 Base Cpff It $3.27M - 0
93.RD Administration $3.23M - 0
98.U72 Ftf Hanga Akazi $3.14M Yes 0
98.U31 All Children Reading-Asia $3.09M - 0
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $3.05M - 0
98.U59 Ftf Rwanda Kwa $3.05M Yes 0
93.RD Fed Meta Analysis Support $3.04M - 0
93.RD Nhlbi Dmc Accel Subots $2.80M - 0
93.RD Nhanes Bp Dc Psus $2.72M - 0
93.RD Clin 0013 T&m $2.68M - 0
98.U68 Construction $2.65M - 0
84.RD 2022 College Scorecard $2.64M - 0
93.RD Ahc Model $2.61M - 0
93.RD The Real Cost Evaluation $2.56M - 0
16.833 National Sexual Assault Kit Initiative $2.49M - 0
93.RD Acl Ope Clin 2 $2.45M - 0
93.RD Catalyze Comm Plat Mgmt $2.39M - 0
93.RD Cpc Pom Q Bs O4 $2.39M - 0
98.U75 Opr Maldives Mgmt $2.25M - 0
93.RD Emerging Tobacco Base $2.22M - 0
98.U67 Mexico Net-Zero Mgmt $2.22M - 0
98.U06 Rdap IV Year 4 $2.18M - 0
98.001 Usaid Foreign Assistance for Programs Overseas $2.17M Yes 0
93.RD The Real Cost $2.12M - 0
93.RD Hiv Continuum Care 2 Oy1 $2.08M - 0
98.U54 Caribbean Esr $2.06M - 0
93.RD Oy1 App Prep $2.05M - 0
93.318 Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security $2.03M - 0
98.U49 Field Office $2.00M - 0
93.RD Oncology Care Model $1.98M - 0
47.RD Sed Base Olms $1.94M - 0
93.RD Tips11 Clin 1 Labor $1.90M - 0
93.RD Ich Cahps Odcs Oy1 $1.90M - 0
98.U73 Iloa Buy in $1.90M - 0
93.RD Eom Base Period $1.83M - 0
93.RD Ndsp Synth Tasks To1 $1.73M - 0
93.RD Acl Tech Sup Clin4001 $1.72M - 0
16.838 Comprehensive Opioid, Stimulant, and Other Substances Use Program $1.72M - 0
93.RD Htprap Osc1b $1.68M - 0
93.RD Oas Cahps Base Yr Labor $1.67M - 0
66.RD Op1 Wqx Attains Cip Sup $1.67M - 0
66.RD Clin 0007 $1.67M - 0
93.RD Ad Hoc $1.65M - 0
93.RD Hh Cahps Oy1 Ot 10 $1.60M - 0
47.RD Sed 2020 2022 $1.58M - 0
93.RD Clonal Hematopoiesis $1.58M - 0
66.RD Circular Economy by $1.57M - 0
93.RD Aphir Rfq Base Year $1.56M - 0
93.RD Tips12 Clin 1 Labor $1.55M - 0
97.RD Eval Soft Target Sec&prev $1.52M - 0
93.RD Ncpi Monitor Interop Proj $1.52M - 0
98.007 Food for Peace Development Assistance Program (dap) $1.51M - 0
66.RD Modeling & Clean Air Op2 $1.50M - 0
12.RD Sigma Algo Dev $1.49M - 0
47.RD Tass Y1 Sciengineerindrpt $1.49M - 0
47.RD Gss Base Year Tm Clins $1.37M - 0
93.RD Design Opts for Future Dc $1.26M - 0
93.RD Pcphs $1.24M - 0
93.RD Med Patient & Comp $1.22M - 0
93.RD Ckc Healthy Kids $1.19M - 0
93.RD Sra Tsk1 Contractual $1.16M - 0
93.RD Tips10 Clin 1 Labor $1.10M - 0
11.307 Covid-19 - Economic Adjustment Assistance $1.07M - 0
66.RD Oil Gas Oy1 $1.05M - 0
93.RD Newborn Screening for Mps $1.02M - 0
97.067 Homeland Security Grant Program $1.01M - 0
12.RD Mtec Warfighter Brian Hti $1.01M - 0
93.RD Nhlbi Innovation $1.00M - 0
93.RD Understanding Digital Adv $998,144 - 0
12.351 Scientific Research - Combating Weapons of Mass Destruction $970,142 - 0
93.RD Eval of Medicare Dpp $949,062 - 0
93.RD Ndsp Cy2 Tasks $936,206 - 0
12.006 National Defense Education Program $899,992 - 0
66.RD Op2 Epa Regions 1 2 3 $887,314 - 0
93.RD Clin 02 $867,597 - 0
93.RD Omas Y1 Quex Dev $845,589 - 0
93.RD Pepc Base Year $837,971 - 0
93.RD Arpa H Partnership $835,233 - 0
81.RD Y1 of 5 Eia2021 Ops Supp $827,037 - 0
66.RD Materials Mgmt App Base $819,444 - 0
93.RD Prenatal and Child Mech $815,983 - 0
93.RD Nrc Campaign 8 To11 $813,114 - 0
93.RD Data Analysis $805,645 - 0
93.839 Blood Diseases and Resources Research $802,050 - 0
66.RD Cordwood Oy1 $793,683 - 0
16.738 Edward Byrne Memorial Justice Assistance Grant Program $755,990 - 0
93.RD Covid-19 - Op1 Year 3 $750,000 - 0
93.RD Als Ratingscale Remoteuse $748,487 - 0
93.RD Nih Seed Accelerator Oy1 $733,548 - 0
93.RD Acquisition of Materials $714,214 - 0
93.RD Firefighter Registry Base $711,589 - 0
16.RD Do Not Use $709,586 - 0
93.RD Covid-19 - Fed Meta Analysis Support $698,653 - 0
93.RD Covid-19 - Data Support Labor $693,585 - 0
93.RD Project Administration $687,393 - 0
93.488 National Harm Reduction Technical Assistance and Syringe Services Program (ssp) Monitoring and Evaluation Funding Opportunity $683,210 - 0
93.RD Dod-Topical Study Phase 1 $667,814 - 0
84.305R Education Research, Development and Dissemination $650,919 - 0
66.RD Etsc $634,239 - 0
19.704 Counter Narcotics $633,593 - 0
93.RD Ttor Epi and Eval Y2 $631,889 - 0
84.RD Post Hs Outcomes Base Cr $629,119 - 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $628,343 - 0
12.RD Sexl Asslt and Alc Misuse $625,015 - 0
10.608 Food for Education $610,870 - 0
93.RD Fda Dmar $604,544 - 0
93.RD Covid-19 - Cber Labor Base $590,966 - 0
81.086 Conservation Research and Development $588,737 - 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $579,271 - 0
93.RD Atdp Compound Purchases $561,272 - 0
16.RD Case Studies $530,576 - 0
66.RD Hls Simulators $530,572 - 0
66.RD Egu Ct Base $527,088 - 0
84.RD Additional Datasets Opt $525,675 - 0
93.RD Clean Slate $520,158 - 0
93.RD Impl Supp Iah Demo $518,772 - 0
93.070 Environmental Public Health and Emergency Response $516,707 - 0
66.RD Gmp Bp $512,142 - 0
93.RD Nrc Campaign To8 $507,858 - 0
12.RD Cbrn Phase 1 $505,439 - 0
93.RD Trs Option Year 4 $498,876 - 0
98.U66 Esho Shikhi to 1 $475,772 - 0
93.315 Rare Disorders: Research, Surveillance, Health Promotion, and Education $450,260 - 0
66.RD Gmi Secretariat Base $439,530 - 0
12.RD Mtec Phase 3 $435,763 - 0
47.RD Conduct the 2021 Gss $431,473 - 0
93.RD Synthesis of Butylminocyc $428,392 - 0
84.305A Education Research, Development and Dissemination $421,222 - 0
11.RD Ropoar Olms $413,320 - 0
47.076 Stem Education (formerly Education and Human Resources) $411,464 - 0
93.RD Mt 4 Hip Prev $411,247 - 0
93.RD Catalyze Preclinical 1 by $407,792 - 0
93.RD 2021 Opas Yr3 $403,776 - 0
93.RD Mitre Rx Pricing $403,534 - 0
98.U77 Eeca Technical $403,262 - 0
93.213 Research and Training in Complementary and Integrative Health $389,917 - 0
93.RD Oy3 Intl Eval Support $386,804 - 0
93.RD Niddk Dr B To1 $386,501 - 0
66.RD Fuel Vehicle Tech Oy1 $368,129 - 0
84.RD Bb 16 20 Cpff $365,710 - 0
93.RD 2023 Ohio Big 3 $357,615 - 0
20.RD Every Day Counts $356,323 - 0
11.RD Protech Weather Atlas 14 $355,075 - 0
66.RD Oar Fund Assist Base Year $352,642 - 0
93.838 Covid-19 - Lung Diseases Research $352,394 - 0
66.RD To1 Ccr Support $352,233 - 0
93.RD Baseline Interview $349,234 - 0
93.974 Family Planning Service Delivery Improvement Research Grants $337,705 - 0
47.RD Hsi Odc Consultant Labor $334,947 - 0
93.RD 2023 McS $332,616 - 0
11.620 Science, Technology, Business And/or Education Outreach $328,037 - 0
93.RD Opioid Eval Clin 0001 $324,547 - 0
93.068 Chronic Diseases: Research, Control, and Prevention $318,470 - 0
84.RD Rel Southeast Yr1 $315,016 - 0
93.RD Cpr-Cons Perc Res $303,601 - 0
93.RD Sdi Algmnt Qual Pub Oy3 $303,479 - 0
16.320 Services for Trafficking Victims $302,684 - 0
93.RD Ofs 2022 Yr2 $302,607 - 0
66.RD Gmi Ccac Op2 $300,324 - 0
93.RD Ehp Base Year $298,466 - 0
45.RD Awarded Grants Addl $297,476 - 0
84.411C Education Innovation and Research (formerly Investing in Innovation (i3) Fund) $296,274 - 0
93.RD Fda Nys Eval $292,596 - 0
66.RD Clin 1 $292,100 - 0
93.065 Laboratory Leadership, Workforce Training and Management Development, Improving Public Health Laboratory Infrastructure $289,720 - 0
66.RD Iron Steel Oy2 $286,694 - 0
11.RD Ntis Extension $284,385 - 0
16.734 Special Data Collections and Statistical Studies $280,314 - 0
66.RD Orcr 22 23 Vi Guidance $279,117 - 0
93.RD Tobacco Form Rsch Oy 1 $278,175 - 0
93.RD Oy 1 Tob Prod Stds $275,009 - 0
97.U03 Project Package 10 $268,985 - 0
66.RD Popchange Brownfields Op1 $262,456 - 0
98.U65 Rihsa to 3 $259,152 - 0
66.RD Modeling and Clean Air Bp $254,554 - 0
93.RD Cmmi Computer Services $253,039 - 0
66.RD Charecterization Dose Y1 $249,957 - 0
66.RD Ethylene Oxide Base $243,812 - 0
81.087 Renewable Energy Research and Development $236,060 - 0
93.310 Covid-19 - Trans-Nih Research Support $235,751 - 0
93.RD Task 5 Eval $234,215 - 0
66.RD Soil Gas Safe Comm $230,083 - 0
93.RD Ndsp Nimh Csdsp To3 $222,696 - 0
12.RD Sgb Omics and Wearables $222,639 - 0
12.420 Military Medical Research and Development $218,040 - 0
84.425D Covid-19, Education Stabilization Fund $212,363 - 0
93.393 Cancer Cause and Prevention Research $211,819 - 0
93.143 Niehs Superfund Hazardous Substances_basic Research and Education $204,457 - 0
66.RD Epa Ow Biosolids Modeling $202,237 - 0
66.RD Taconite Oy1 $202,027 - 0
17.RD Educator Ra Intermediary $200,287 - 0
11.RD Clin 1 Protech Atlas 15 $199,212 - 0
93.845 Promoting Population Health Through Increased Capacity in Alcohol Epidemiology $197,686 - 0
66.RD Forest Products Ars by $196,470 - 0
93.350 National Center for Advancing Translational Sciences $195,573 - 0
93.RD Service Component 1 Base $194,435 - 0
66.RD Pulp and Paper Sector by $191,336 - 0
66.RD Nprm Support 23 $188,516 - 0
84.411 Education Innovation and Research (formerly Investing in Innovation (i3) Fund) $187,799 - 0
93.397 Cancer Centers Support Grants $184,896 - 0
66.RD Ghgi Base Period $181,343 - 0
93.RD Ecpp W Mult Ccs $179,325 - 0
93.067 Global Aids $175,507 - 0
93.RD Ndsp Admin To2 $173,682 - 0
93.RD By Medicaid Ben Cov Ovrsi $171,049 - 0
93.092 Affordable Care Act (aca) Personal Responsibility Education Program $168,146 - 0
93.RD 2023 Omas Data Ta $167,238 - 0
66.RD Forest Products Op $166,731 - 0
66.RD Epa Ccd Econ Wide Modelbp $163,778 - 0
16.839 Stop School Violence $162,723 - 0
93.RD Respect $162,668 - 0
93.RD Smh Op1 Clin 0003-0005 $162,074 - 0
66.RD Ethy Oxide Base Year $161,773 - 0
66.RD Storage Tanks Model $157,837 - 0
93.361 Nursing Research $157,079 - 0
66.RD Public Hearing Supp Oy1 $153,867 - 0
93.RD Fda Next Legends $153,660 - 0
11.016 Statistical, Research, and Methodology Assistance $150,444 - 0
93.RD Clin7 Bp Contract Mgmt $150,285 - 0
47.RD Americas Data Hub $149,784 - 0
93.441 Indian Self-Determination $149,443 - 0
66.RD Epa Support for Wqx Atta $149,393 - 0
93.279 Drug Abuse and Addiction Research Programs $146,460 - 0
93.RD Clin 0001 T&m $146,022 - 0
93.RD Biomarker Eval $144,268 - 0
93.110 Maternal and Child Health Federal Consolidated Programs $143,998 - 0
10.RD Nass Engineer Support Oy1 $140,727 - 0
11.405 Cooperative Institute (inter-Agency Funded Activities) $138,316 - 0
93.136 Injury Prevention and Control Research and State and Community Based Programs $138,054 - 0
84.RD Ope Postsecondary Anal $136,659 - 0
93.RD Tx Substance Use Disorder $135,833 - 0
93.RD Fda Canada Base Period $135,551 - 0
66.RD Gasoline Distribution Y2 $135,519 - 0
93.RD Health Comm Research $131,691 - 0
98.U31 Acl Management and Ops $129,464 - 0
66.RD Iron and Steel Sector by $128,043 - 0
93.RD Tbesc III Ltbi Labor Odcs $127,170 - 0
66.RD Tech Support Eval Ccr $125,703 - 0
93.RD Hos Sampling/mgmt Yr 4 $123,656 - 0
98.U74 Cr Wash Clin 1 $122,216 - 0
17.RD Early Implementation $121,435 - 0
66.RD Oaqps Rule Support Oy1 $121,195 - 0
66.RD Uvc Disinfection $120,564 - 0
66.RD Gmi Asg Option 2 $118,537 - 0
43.RD Basepd Helpdesk Ops Spprt $116,195 - 0
93.RD Drug Discovery Initiative $115,537 - 0
10.328 Food Safety Outreach Program $114,348 - 0
66.RD Wincmtp Modeling Supt Op1 $114,014 - 0
16.827 Justice Reinvestment Initiative $112,672 - 0
66.RD Use of Vr Training $112,369 - 0
12.600 Community Investment $110,763 - 0
12.RD Female I-Ast $108,880 - 0
66.309 Surveys, Studies, Investigations, Training and Special Purpose Activities Relating to Environmental Justice $107,791 - 0
93.RD National Ed on Nicotine $107,535 - 0
93.RD Rustec $106,697 - 0
66.RD Lg Bldg Vapor Final Docu $106,579 - 0
66.RD Triennial Report Lbr Clin $105,358 - 0
66.RD Petroleum Refineries by $102,826 - 0
66.RD Oaqps Econ Modeling Oy1 $101,971 - 0
16.812 Second Chance Act Reentry Initiative $101,661 - 0
66.RD Covid-19 - Mme Oil Gas Baseyr $100,810 - 0
10.253 Consumer Data and Nutrition Research $99,911 - 0
85.002 McC Foreign Assistance for Overseas Programs $98,347 - 0
93.RD Dhhs Onc Phit Evaluation $95,951 - 0
97.RD Dhs St Ipa Owens $95,867 - 0
66.RD Epa Waste Resiliency Op $95,335 - 0
66.RD Primary Copper by $95,328 - 0
12.RD Dose Opt Tbi Ct Study Ope $94,188 - 0
19.017 Environmental and Scientific Partnerships and Programs $92,264 - 0
11.RD Co8 Snap Travel Olms $89,486 - 0
84.U01 Osep Swift $89,427 - 0
93.RD Opioid Response Fy23 25 $89,098 - 0
16.RD Dc Preparation $88,447 - 0
98.U49 Burma to Rev Level $88,417 - 0
43.001 Science $88,404 - 0
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation’s Health $88,299 - 0
66.RD Task 1 Mgmt Qa Qapp $87,274 - 0
66.RD Tech Supp on Biofuels $86,266 - 0
47.RD Ncses Sqd Implementation $86,142 - 0
84.RD 2it-Mgls:17-Cpff:it Tasks $85,989 - 0
66.RD Vapor Phase Pfas $85,867 - 0
66.RD Neshap Option Yr 1 $85,499 - 0
66.RD Epa Region 9 $83,480 - 0
10.557 Wic Special Supplemental Nutrition Program for Women, Infants, and Children $82,518 - 0
93.087 Enhance Safety of Children Affected by Substance Abuse $81,930 - 0
12.RD Dhapp Odcs $80,290 - 0
93.RD Ohiorise $77,878 - 0
93.103 Food and Drug Administration Research $77,692 - 0
81.089 Fossil Energy Research and Development $76,709 - 0
47.RD Low Burden Respondents $76,347 - 0
93.RD Ndsp Nimh Csdsp To5 $75,805 - 0
66.RD Ozone Base Year $75,432 - 0
93.865 Child Health and Human Development Extramural Research $71,609 - 0
93.RD Nymac Yr 2 $71,263 - 0
66.RD Ggicbs Base Period $70,764 - 0
93.RD Umd Nih Dc Facil Yr 5 $69,808 - 0
93.RD Ad Hoc Requests $69,681 - 0
47.041 Covid-19 - Engineering $69,227 - 0
16.746 Capital Case Litigation Initiative $68,000 - 0
93.RD Implied Claims Odcs $66,958 - 0
93.224 Health Center Program (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $66,322 - 0
93.361 Structural Racism Discrim $60,836 - 0
93.RD Reds III Phase 3 To4 $58,605 - 0
47.041 Engineering $58,138 - 0
12.RD Scientific Support Oy 2/4 $58,050 - 0
66.RD Advancing Critical Ld Oy1 $55,921 - 0
93.RD Cdrh Ppst Bi Tm Olms $53,106 - 0
93.347 Trusted Exchange Framework and Common Agreement (tefca) Recognized Coordinating Entity (rce) Cooperative Agreement $52,380 - 0
93.396 Cancer Biology Research $52,102 - 0
12.350 Department of Defense Hiv/aids Prevention Program $51,306 - 0
93.RD Zip 2 0 Ndash to 21 $50,250 - 0
93.RD Aphir Prep Dce Olms $49,854 - 0
93.242 Mental Health Research Grants $49,235 - 0
66.RD Fy22 Ccr Rulemakings $49,099 - 0
11.RD Ntis Process Inter Maps $48,443 - 0
12.RD Tdm Sim-Clin 0001-0002 $47,399 - 0
66.RD Warts Streamflow Method $46,958 - 0
93.113 Environmental Health $46,096 - 0
93.RD Collab Pharm Batten Pm $45,751 - 0
93.307 Minority Health and Health Disparities Research $45,487 - 0
93.395 Cancer Treatment Research $43,784 - 0
66.U01 Hei Qa Ebelt Rich Study $43,776 - 0
93.RD Federal Meta Yr1 $43,599 - 0
16.582 Crime Victim Assistance/discretionary Grants $43,478 - 0
14.902 Lead Technical Studies Grants $43,131 - 0
12.RD Mtec Chem Bio Exposure $41,211 - 0
93.RD Meth Dissemination Yr3 $40,682 - 0
93.837 Cardiovascular Diseases Research $38,799 - 0
93.RD Main Studies Kantar $37,853 - 0
66.RD 3 3 2 Optl Acm $37,770 - 0
66.RD Cost Manual Base Period $37,442 - 0
16.825 Smart Prosecution Initiative $37,225 - 0
93.RD Oud Mat/nida Phase 3 $36,742 - 0
93.RD Ambassadorrs for Health $36,505 - 0
81.135 Advanced Research Projects Agency - Energy $35,680 - 0
93.RD Compound Purchases $34,860 - 0
66.RD Waste and Energy Sect Oy1 $34,785 - 0
16.RD Capital Litigation Init $34,284 - 0
66.RD Hei Collett Study $34,073 - 0
16.045 Community-Based Violence Intervention and Prevention Initiative $33,097 - 0
93.RD Fda To10 Olms $32,982 - 0
93.RD Rho Redcap Consulting Yr3 $32,657 - 0
93.RD Fy23 Uspstf T&a $32,648 - 0
16.560 National Institute of Justice Research, Evaluation, and Development Project Grants $31,507 - 0
66.RD Amend Cement Neshap by $30,472 - 0
66.RD Pgvp Bp $30,167 - 0
93.172 Human Genome Research $29,752 - 0
47.079 Office of International Science and Engineering $28,332 - 0
99.RD Medpacacshospmeasure $27,570 - 0
98.U05 Rwanda Psdag $26,928 - 0
93.RD Fda Cfsan Olm $25,662 - 0
93.RD Slin 2aa Op1 $25,567 - 0
16.RD Ovw Campus Program Needs $25,285 - 0
11.U01 Wvded Ta Gen Ca $25,248 - 0
93.RD Oh Soars 2023 Yr1 $25,125 - 0
66.RD Ncpb Cmop Bp $24,685 - 0
99.RD Hcbs Interviews Reports $24,324 - 0
93.989 International Research and Research Training $22,953 - 0
93.RD Engage Implement Science $22,810 - 0
66.RD Cost Manual Base $22,156 - 0
93.RD Postadopt Instability Sc4 $22,005 - 0
93.838 Lung Diseases Research $21,897 - 0
93.RD Measures Dev $21,675 - 0
16.745 Criminal and Juvenile Justice and Mental Health Collaboration Program $21,164 - 0
93.RD Fg Analysis and Report $20,969 - 0
84.305S Covid-19 - Education Research, Development and Dissemination $20,934 - 0
10.RD Opt Yr 4 Labor Foc Groups $20,295 - 0
93.RD Res to Pract Ed Resources $19,994 - 0
93.RD Oh Soars 2022 Yr2 $19,887 - 0
93.RD Base Year Ghs $19,468 - 0
66.RD Epa Ow It Portfolio To2 $19,257 - 0
16.RD Doj Litigative Services $19,140 - 0
98.U65 Rihsa to 2 $19,117 - 0
64.RD Va Teams Y1 $18,600 - 0
93.RD Med Educate Lc Mm $18,577 - 0
66.RD Hosp Ster Eo by $17,860 - 0
98.U02 Haiti Leve $16,486 - 0
66.RD Optimizing Materials Mgmt $15,886 - 0
93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research $15,461 - 0
93.RD Shout Toolkit Pm $14,869 - 0
93.RD Fy22 Uspstf T and A $14,802 - 0
16.710 Public Safety Partnership and Community Policing Grants $14,617 - 0
66.RD Dry Cleaning Oy1 $14,472 - 0
10.025 Plant and Animal Disease, Pest Control, and Animal Care $14,276 - 0
66.RD Site Remediation Base $14,181 - 0
93.RD 2019 Hcps $13,536 - 0
93.RD Jackson Heart Health $13,212 - 0
93.273 Alcohol Research Programs $13,069 - 0
66.RD To1 Mprsap Bp $12,879 - 0
93.RD Oh Soars 2021 Yr3 $12,310 - 0
93.RD Optimum $12,176 - 0
93.654 Indian Health Service Behavioral Health Programs $11,733 - 0
93.RD Sc MD Starnet Survey $11,641 - 0
97.RD Formative Research $11,187 - 0
93.RD Data Migration $10,679 - 0
66.RD Orcr 22 Sup Vi Guidance $10,355 - 0
93.RD Rural Cohort Study II $10,342 - 0
66.RD Magnesium Base $10,089 - 0
93.RD 2021 Opas Y2 $9,832 - 0
47.084 Nsf Technology, Innovation, and Partnerships $9,744 - 0
93.231 Epidemiology Cooperative Agreements $8,924 - 0
93.262 Occupational Safety and Health Program $8,811 - 0
93.RD Sample Plan $8,629 - 0
66.RD Wincmtp V3 0 Modeling $8,218 - 0
93.855 Allergy and Infectious Diseases Research $8,149 - 0
93.RD Rce Program Oasis Caf $7,576 - 0
66.RD Epa Ow It Portfolio To1 $7,501 - 0
93.433 Acl National Institute on Disability, Independent Living, and Rehabilitation Research $7,448 - 0
93.RD Olms Dosage Form Pres $7,234 - 0
12.007 Military Health Services Research (mhsr) $7,060 - 0
30.RD Eeco Proj Management $6,860 - 0
93.RD Oasis Caf Cr Nisvs 5 $6,837 - 0
97.RD Cve Eval Fy20 T E $6,669 - 0
66.RD Clean Air Act Oy 1 $6,480 - 0
93.RD Litcoin Foundational Know $6,479 - 0
93.394 Cancer Detection and Diagnosis Research $6,461 - 0
93.RD Sicrcs Eval - Travel $6,437 - 0
93.RD Als Bci Preference Olm $6,337 - 0
93.RD Eftouch Billable $6,218 - 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $6,183 - 0
93.RD Rural Cohort Study III $5,888 - 0
66.461 Regional Wetland Program Development Grants $5,634 - 0
93.866 Aging Research $5,172 - 0
93.RD Brazil Scd Study $5,096 - 0
93.297 Teenage Pregnancy Prevention Program $4,960 - 0
93.RD Dissemination $4,891 - 0
93.RD Nrc Campaign 9 To14 $4,870 - 0
66.RD Rppsa Petroleum Refinery $4,851 - 0
66.034 Covid-19 - Surveys, Studies, Research, Investigations, Demonstrations, and Special Purpose Activities Relating to the Clean Air Act $4,657 - 0
93.RD Tobacco Retail Project $4,501 - 0
93.RD Viqi Clin 1 Data Dissem $4,324 - 0
93.RD Eua Promotion Anlys Olms $4,232 - 0
66.RD Primary Copper Smelt Opt1 $4,145 - 0
16.RD Nij Rh Project Labor $3,908 - 0
16.026 Ovw Research and Evaluation Program $3,716 - 0
93.RD Promising Themes $3,714 - 0
93.RD Cognitive Testing Olm $3,488 - 0
66.RD Carbon Black $2,991 - 0
98.U21 El Salvador Hep $2,879 - 0
66.RD Vapor Intrusion $2,877 - 0
93.RD Viqi Clin6 T3 $2,758 - 0
93.RD Uv4me Intervention $2,716 - 0
93.RD Cdcs Colorectal C/e Comp $2,689 - 0
47.070 Computer and Information Science and Engineering $2,670 - 0
93.RD Postadopt Instability Sc1 $2,587 - 0
66.RD Op1 Refractories $2,449 - 0
93.RD Cancer Reg Data Travel $2,394 - 0
66.RD Covid-19 - Modeling & Clean Air Op2 $2,308 - 0
93.RD By Adp Wtt Travel $2,200 - 0
12.RD Selsym Pre Ind Mrl $2,169 - 0
93.RD Analysis of Mysmartskin $2,005 - 0
81.RD Ornl Riverware Training $1,796 - 0
93.RD Nci Gwas $1,699 - 0
98.U49 Sufia to Rev Level $1,675 - 0
66.RD Soil Vapor Extraction Pil $1,593 - 0
66.RD Evaluating of Methylmer $1,540 - 0
93.RD Moud Study Olm $1,311 - 0
66.RD Effects of Climate Change $1,226 - 0
93.RD Gyts 2022 Cr $1,127 - 0
81.RD Cbecs Redesign Pilot $847 - 0
93.RD Catalyze Pre Clinical 2 $832 - 0
81.RD 2020 Recs Hh Survey Yr $830 - 0
93.RD Fda Adherence Olms $741 - 0
93.RD Foodinsecuripa $605 - 0
66.RD Pfas Support $585 - 0
93.RD 2021 Opas Year 2b $570 - 0
93.RD Comp Exp Conf Labor Only $477 - 0
93.RD Clin 2 Optional Serv Comp $468 - 0
93.RD Diabetes Prevent Base Yr $467 - 0
98.U31 Merit Imp Reading Instruc $371 - 0
11.609 Measurement and Engineering Research and Standards $366 - 0
93.RD Aspecare Optional Rr $306 - 0
93.RD Ndsp Synthesis Tasks $282 - 0
93.RD Oh Soars 2022 Yr3 $251 - 0
93.RD Drive 5 $229 - 0
66.RD Use of Vr to Augment Situ $193 - 0
93.RD Match Data Collection $167 - 0
16.RD Nrrc Tta $142 - 0
10.707 Research Joint Venture and Cost Reimbursable Agreements $137 - 0
93.RD Project Management $125 - 0
11.432 National Oceanic and Atmospheric Administration (noaa) Cooperative Institutes $121 - 0
93.RD Natl Media Camp: Tips6 $114 - 0
66.RD Otaq Support Service Op4 $91 - 0
15.RD 3 - Proj. Management $83 - 0
15.560 Secure Water Act – Research Agreements $79 - 0
93.RD Fpar 1.0 Yr3 $71 - 0
47.RD Wo21 103 508 Content $31 - 0
47.RD Olm Ecds Support $11 - 0
93.RD Fertility Dissemination $6 - 0
98.U01 Wildlife Asia $6 - 0
93.RD Clin 4 Olms $5 - 0
93.RD Y2 9 Ro Model $3 - 0
12.RD Uipe Fos Gp Testing 2021 $1 - 0
47.083 Integrative Activities $0 - 0
93.RD Cdc Pt Program $0 - 0
93.RD Zika in Pregnancy to 18 $0 - 0
93.RD Comm and Digital Supp Ser $0 - 0
93.RD Ich Cahps Svy Y3 of 3 $0 - 0
93.RD 2022 Opas $0 - 0
93.RD Lab Medicine Yr 3 Opt 2 $-1 - 0
93.RD Covid-19 - Covid19 T&m Olms $-1 - 0
20.RD Driving Attitues Yr 5 $-4 - 0
93.RD Travel $-4 - 0
66.RD Climate Change Base Pd $-5 - 0
93.RD Tf Rs Support $-10 - 0
19.705 Trans-National Crime $-18 - 0
93.RD Spars $-19 - 0
81.RD Po# 5000-121 $-22 - 0
47.074 Biological Sciences $-29 - 0
93.RD Data Collection $-58 - 0
10.RD Trade Algorithms $-91 - 0
12.RD Air 2022- Uipe $-147 - 0
12.800 Air Force Defense Research Sciences Program $-189 - 0
66.509 Science to Achieve Results (star) Research Program $-295 - 0
66.RD Magnesium $-429 - 0
12.RD Covid-19 - Testing of Cbrn $-466 - 0
93.RD Clin 6 $-633 - 0
93.RD Particle Size Dist $-866 - 0
93.RD Routine Analysis Qc Testi $-992 - 0
98.U46 Nigeria E Wash $-1,375 - 0
66.RD To 6 Rev 40 Cfr Part 192 $-1,396 - 0
93.RD Pep Option Year 3 $-1,587 - 0
98.U30 Hctm to 38 Ext Prd $-2,148 - 0
93.RD MD All Payer $-2,490 - 0
98.U78 Wb Egra $-3,001 - 0
93.RD Nimhd Pilot $-4,543 - 0
66.511 Office of Research and Development Consolidated Research/training/fellowships $-4,626 - 0
93.360 Biomedical Advanced Research and Development Authority (barda), Biodefense Medical Countermeasure Development $-6,483 - 0
93.RD Pt Pref Info Tm Olms $-7,237 - 0
66.RD Green Gas Option $-7,635 - 0
93.778 Medical Assistance Program $-10,125 - 0
93.RD Omas Y2 Data Collection $-14,945 - 0
93.RD Positev $-19,762 - 0
93.RD Omcee2 Data Collection $-26,251 - 0
93.RD Omcee Data Collection $-27,005 - 0
98.U03 Lread Local Sub Mgmt $-34,468 - 0
93.RD Omres Data Collection $-61,339 - 0
98.U08 Tanzania Protect $-85,342 - 0

Contacts

Name Title Type
JJHCMK4NT5N3 Steven Cornwell Auditee
9194855563 Stephanie Brown Auditor
No contacts on file

Notes to SEFA

Title: 1. BASIS OF PRESENTATION Accounting Policies: The SEFA has been prepared in accordance with the accrual basis of accounting and with accounting principles generally accepted in the United States of America, and is consistent with the preparation of the Institute’s consolidated financial statements. Amounts reflected in the SEFA include only expenditures of federal awards whereas the corresponding amounts reported in the consolidated financial statements also include expenditures of federal fixed price contracts and nonfederal awards. Such expenditures are recognized following the applicable cost principles wherein certain types of expenditures are unallowable. Negative amounts shown on the SEFA represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. An award is considered expended when the activity related to the award occurs. The activity generally pertains to events requiring compliance with laws, regulations, and the provisions of contract and grant agreements. Direct costs have been recognized on the accrual basis of accounting when costs are incurred. For time and materials contracts, expenditures are recognized as hours and costs are incurred based on negotiated rates. Fees on cost-plus contracts are recognized as costs are incurred and expenditures include a proportionate share of the fees earned. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). The consolidated financial statements include the accounts of the Institute and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The preparation of the consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements. Actual results could differ from those estimates. De Minimis Rate Used: N Rate Explanation: The Institute has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance The schedule of expenditures of federal awards (the “SEFA”) includes the federal award activity of the Research Triangle Institute (the “Institute”) under programs of the federal government for the year ended September 30, 2023. The information in the SEFA is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (“2 CFR”) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the SEFA presents only a selected portion of the operations of the Institute, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Institute. Assistance listing numbers (“ALN numbers”) are unique numbers assigned to identify Federal Assistance Listings, the publicly available listing of Federal assistance programs managed and administered by the General Services Administration, formerly known as the Catalog of Federal Domestic Assistance. As provided for in the Uniform Guidance, when no ALN number is assigned, the purpose of federal contracts from the same federal agency is assessed, and those made for the same purpose are combined and considered one program. Programs without an ALN number are presented with only the federal agency’s two-digit prefix followed by the abbreviation “RD” for those programs in the research and development cluster or “U” (i.e. unknown) and sequentially numbered by federal agency in place of an ALN number. The Institute assigns sequential numbers on an annual basis unless a program had already been assigned a number on the SEFA in a prior year. The federal agency two-digit prefixes are as follows:(See NOTES TO THE SCHEDULE OF EXPENDITURES OF FEDERAL AWARDS -Note 1 Table)
Title: 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Accounting Policies: The SEFA has been prepared in accordance with the accrual basis of accounting and with accounting principles generally accepted in the United States of America, and is consistent with the preparation of the Institute’s consolidated financial statements. Amounts reflected in the SEFA include only expenditures of federal awards whereas the corresponding amounts reported in the consolidated financial statements also include expenditures of federal fixed price contracts and nonfederal awards. Such expenditures are recognized following the applicable cost principles wherein certain types of expenditures are unallowable. Negative amounts shown on the SEFA represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. An award is considered expended when the activity related to the award occurs. The activity generally pertains to events requiring compliance with laws, regulations, and the provisions of contract and grant agreements. Direct costs have been recognized on the accrual basis of accounting when costs are incurred. For time and materials contracts, expenditures are recognized as hours and costs are incurred based on negotiated rates. Fees on cost-plus contracts are recognized as costs are incurred and expenditures include a proportionate share of the fees earned. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). The consolidated financial statements include the accounts of the Institute and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The preparation of the consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements. Actual results could differ from those estimates. De Minimis Rate Used: N Rate Explanation: The Institute has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance The SEFA has been prepared in accordance with the accrual basis of accounting and with accounting principles generally accepted in the United States of America, and is consistent with the preparation of the Institute’s consolidated financial statements. Amounts reflected in the SEFA include only expenditures of federal awards whereas the corresponding amounts reported in the consolidated financial statements also include expenditures of federal fixed price contracts and nonfederal awards. Such expenditures are recognized following the applicable cost principles wherein certain types of expenditures are unallowable. Negative amounts shown on the SEFA represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. An award is considered expended when the activity related to the award occurs. The activity generally pertains to events requiring compliance with laws, regulations, and the provisions of contract and grant agreements. Direct costs have been recognized on the accrual basis of accounting when costs are incurred. For time and materials contracts, expenditures are recognized as hours and costs are incurred based on negotiated rates. Fees on cost-plus contracts are recognized as costs are incurred and expenditures include a proportionate share of the fees earned. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). The consolidated financial statements include the accounts of the Institute and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The preparation of the consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements. Actual results could differ from those estimates.
Title: 3. INDIRECT COST RATE Accounting Policies: The SEFA has been prepared in accordance with the accrual basis of accounting and with accounting principles generally accepted in the United States of America, and is consistent with the preparation of the Institute’s consolidated financial statements. Amounts reflected in the SEFA include only expenditures of federal awards whereas the corresponding amounts reported in the consolidated financial statements also include expenditures of federal fixed price contracts and nonfederal awards. Such expenditures are recognized following the applicable cost principles wherein certain types of expenditures are unallowable. Negative amounts shown on the SEFA represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. An award is considered expended when the activity related to the award occurs. The activity generally pertains to events requiring compliance with laws, regulations, and the provisions of contract and grant agreements. Direct costs have been recognized on the accrual basis of accounting when costs are incurred. For time and materials contracts, expenditures are recognized as hours and costs are incurred based on negotiated rates. Fees on cost-plus contracts are recognized as costs are incurred and expenditures include a proportionate share of the fees earned. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). The consolidated financial statements include the accounts of the Institute and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The preparation of the consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements. Actual results could differ from those estimates. De Minimis Rate Used: N Rate Explanation: The Institute has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance The Institute has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. Indirect costs are recovered from the federal government by applying a federally negotiated indirect cost rate or by allocating these costs among benefiting programs in accordance with a federally approved plan. Each program’s share of indirect costs is recognized on the accompanying SEFA.
Title: 4.        RELATIONSHIP TO FEDERAL FINANCIAL REPORTS Accounting Policies: The SEFA has been prepared in accordance with the accrual basis of accounting and with accounting principles generally accepted in the United States of America, and is consistent with the preparation of the Institute’s consolidated financial statements. Amounts reflected in the SEFA include only expenditures of federal awards whereas the corresponding amounts reported in the consolidated financial statements also include expenditures of federal fixed price contracts and nonfederal awards. Such expenditures are recognized following the applicable cost principles wherein certain types of expenditures are unallowable. Negative amounts shown on the SEFA represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. An award is considered expended when the activity related to the award occurs. The activity generally pertains to events requiring compliance with laws, regulations, and the provisions of contract and grant agreements. Direct costs have been recognized on the accrual basis of accounting when costs are incurred. For time and materials contracts, expenditures are recognized as hours and costs are incurred based on negotiated rates. Fees on cost-plus contracts are recognized as costs are incurred and expenditures include a proportionate share of the fees earned. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). The consolidated financial statements include the accounts of the Institute and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The preparation of the consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements. Actual results could differ from those estimates. De Minimis Rate Used: N Rate Explanation: The Institute has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance The regulations and guidelines governing the preparation of federal financial reports vary by federal agency and among programs administered by the same agency. Accordingly, the amounts reported in the federal financial reports do not necessarily agree with the amounts reported in the accompanying SEFA, which is prepared as explained in Notes 1 and 2 above.
Title: 5. SUBRECIPIENTS Accounting Policies: The SEFA has been prepared in accordance with the accrual basis of accounting and with accounting principles generally accepted in the United States of America, and is consistent with the preparation of the Institute’s consolidated financial statements. Amounts reflected in the SEFA include only expenditures of federal awards whereas the corresponding amounts reported in the consolidated financial statements also include expenditures of federal fixed price contracts and nonfederal awards. Such expenditures are recognized following the applicable cost principles wherein certain types of expenditures are unallowable. Negative amounts shown on the SEFA represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. An award is considered expended when the activity related to the award occurs. The activity generally pertains to events requiring compliance with laws, regulations, and the provisions of contract and grant agreements. Direct costs have been recognized on the accrual basis of accounting when costs are incurred. For time and materials contracts, expenditures are recognized as hours and costs are incurred based on negotiated rates. Fees on cost-plus contracts are recognized as costs are incurred and expenditures include a proportionate share of the fees earned. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). The consolidated financial statements include the accounts of the Institute and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The preparation of the consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements. Actual results could differ from those estimates. De Minimis Rate Used: N Rate Explanation: The Institute has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance The Institute must make case-by-case determinations whether each agreement it makes for the disbursement of federal program funds casts the party receiving the funds as a subrecipient or a contractor based on the Uniform Guidance definitions and management’s judgement. The total amount identified as provided to subrecipients during the year ended September 30, 2023 was $74.7 million.